Crossref
journal-article
Elsevier BV
The American Journal of Pathology (78)
Bibliography
Raz, V., Routledge, S., Venema, A., Buijze, H., van der Wal, E., Anvar, S., Straasheijm, K. R., Klooster, R., Antoniou, M., & van der Maarel, S. M. (2011). Modeling Oculopharyngeal Muscular Dystrophy in Myotube Cultures Reveals Reduced Accumulation of Soluble Mutant PABPN1 Protein. The American Journal of Pathology, 179(4), 1988â2000.
Authors
10
- Vered Raz (first)
- Samantha Routledge (additional)
- Andrea Venema (additional)
- Hellen Buijze (additional)
- Erik van der Wal (additional)
- SeyedYahya Anvar (additional)
- Kirsten R. Straasheijm (additional)
- Rinse Klooster (additional)
- Michael Antoniou (additional)
- Silvère M. van der Maarel (additional)
References
55
Referenced
37
10.1093/hmg/9.6.909
/ Hum Mol Genet / Fourteen and counting: unraveling trinucleotide repeat diseases by Cummings (2000)10.1016/j.gde.2005.04.003
/ Curr Opin Genet Dev / The other trinucleotide repeat: polyalanine expansion disorders by Albrecht (2005)10.1016/j.tig.2003.11.002
/ Trends Genet / Alanine tracts: the expanding story of human illness and trinucleotide repeats by Brown (2004)10.1038/nm1066
/ Nat Med / Protein aggregation and neurodegenerative disease by Ross (2004)10.1038/ng0298-164
/ Nat Genet / Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy by Brais (1998)10.1016/0092-8674(91)90119-J
/ Cell / A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation by Wahle (1991)10.1016/0167-4781(94)00248-2
/ Biochim Biophys Acta / 3′-end cleavage and polyadenylation of mRNA precursors by Wahle (1995)10.1016/S0960-8966(97)00077-1
/ Neuromuscul Disord / Recent studies on oculopharyngeal muscular dystrophy in Quebec by Bouchard (1997)10.1097/00005053-191503000-00001
/ J Nerv Ment Dis / Progressive vagus-glossopharyngeal paralysis with ptosis: contribution the group of family diseases by Taylor (1915)10.1093/oxfordjournals.hmg.a018924
/ Hum Mol Genet / Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA by Calado (2000)10.1007/BF00692226
/ Acta Neuropathol / Nuclear inclusions in oculopharyngeal dystrophy by Tome (1980)10.1016/S0960-8966(97)00085-0
/ Neuromuscul Disord / Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy by Tome (1997)10.1093/hmg/ddh101
/ Hum Mol Genet / Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus by Berciano (2004)10.1016/j.mcn.2007.12.012
/ Mol Cell Neurosci / Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions by Villagra (2008)10.1016/j.yexcr.2008.02.005
/ Exp Cell Res / PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression by Klein (2008)10.1261/rna.7217105
/ RNA / In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1 by Tavanez (2005)10.1038/sj.emboj.7601117
/ EMBO J / A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1 by Chartier (2006)10.1007/s11910-009-0012-y
/ Curr Neurol Neurosci Rep / Oculopharyngeal muscular dystrophy: a polyalanine myopathy by Brais (2009)10.1093/hmg/ddn109
/ Hum Mol Genet / Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1 by Catoire (2008)10.1038/nm1242
/ Nat Med / Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice by Davies (2005)10.1093/hmg/ddp101
/ Hum Mol Genet / Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo by Chartier (2009)10.1093/hmg/ddi422
/ Hum Mol Genet / Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy by Davies (2006)10.1093/hmg/ddq098
/ Hum Mol Genet / Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres by Trollet (2010)10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.0.CO;2-O
/ Ann Neurol / Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease by Blumen (1999)10.1093/hmg/ddh017
/ Hum Mol Genet / Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy by Hino (2004)10.1093/hmg/ddp569
/ Hum Mol Genet / Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis by Apponi (2010)10.1093/hmg/10.11.1129
/ Hum Mol Genet / The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression by Kim (2001)10.1016/j.bbrc.2005.12.078
/ Biochem Biophys Res Commun / Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis by Wang (2006)10.1186/2044-5040-1-15
/ Skelet Muscle / Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients by Anvar (2011)10.1006/prep.1995.1015
/ Protein Expr Purif / Further development of the locus control region/murine erythroleukemia expression system: high level expression and characterization of recombinant human calcitonin receptor by Needham (1995)10.1016/j.ygeno.2006.01.009
/ Genomics / The human desmin locus: gene organization and LCR-mediated transcriptional control by Tam (2006)10.2144/96201pf01
/ Biotechniques / Vectors for expression and secretion of FLAG epitope-tagged proteins in mammalian cells by Chubet (1996)10.1006/dbio.1994.1103
/ Dev Biol / Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines by Morgan (1994)10.1016/S0531-5565(01)00220-0
/ Exp Gerontol / The biochemistry of aging muscle by Carmeli (2002)10.1093/bioinformatics/btg382
/ Bioinformatics / A global test for groups of genes: testing association with a clinical outcome by Goeman (2004)10.1242/jcs.03180
/ J Cell Sci / Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells by Raz (2006)10.1093/hmg/ddi432
/ Hum Mol Genet / Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody by Verheesen (2006)10.1093/hmg/ddg293
/ Hum Mol Genet / Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy by Abu-Baker (2003)10.1136/jmg.2003.014548
/ J Med Genet / Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy by Bao (2004)10.1016/j.nbd.2004.10.019
/ Neurobiol Dis / PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions by Corbeil-Girard (2005)10.1016/j.yexcr.2008.02.005
/ Exp Cell Res / PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression by Klein (2008)10.1016/j.nbd.2007.02.004
/ Neurobiol Dis / Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy by Messaed (2007)10.1093/nar/26.3.721
/ Nucleic Acids Res / Efficient 3′-end formation of human beta-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reaction by Antoniou (1998)10.1002/j.1460-2075.1990.tb08100.x
/ EMBO J / Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression by Collis (1990)10.1093/emboj/18.10.2855
/ EMBO J / Inefficient processing impairs release of RNA from the site of transcription by Custodio (1999)10.1093/embo-reports/kvf173
/ EMBO Rep / A novel function for the U2AF 65 splicing factor in promoting pre-mRNA 3′-end processing by Millevoi (2002)10.1093/hmg/ddm382
/ Hum Mol Genet / Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation by Davies (2008)10.1093/hmg/10.21.2341
/ Hum Mol Genet / Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death by Fan (2001)10.1038/embor.2009.192
/ EMBO Rep / Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities by Hjerpe (2009)10.4161/rna.7.3.11649
/ RNA Biol / Crossing the borders: poly(A)-binding proteins working on both sides of the fence by Lemay (2010)10.1096/fj.04-2578fje
/ FASEB J / Altered proteasome structure, function, and oxidation in aged muscle by Ferrington (2005)10.1016/j.bbaexp.2004.03.008
/ Biochim Biophys Acta / Structure and function of poly(A) binding proteins by Kuhn (2004)10.1074/jbc.M109.018226
/ J Biol Chem / Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor by Kühn (2009)10.1038/ejhg.2008.227
/ Eur J Hum Genet / Dystrophia myotonia: why focus on foci? by Junghans (2009)10.1093/nar/gkq1323
/ Nucleic Acids Res / Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference by de Mezer (2011)
Dates
Type | When |
---|---|
Created | 14 years ago (Aug. 19, 2011, 1:28 p.m.) |
Deposited | 1 year, 6 months ago (Feb. 7, 2024, 4:08 p.m.) |
Indexed | 1 month ago (July 22, 2025, 6:43 a.m.) |
Issued | 13 years, 10 months ago (Oct. 1, 2011) |
Published | 13 years, 10 months ago (Oct. 1, 2011) |
Published Print | 13 years, 10 months ago (Oct. 1, 2011) |
Funders
2
Muscular Dystrophy Association
10.13039/100005202
Region: Americas
gov (Associations and societies (private and public))
Labels
2
- Muscular Dystrophy Association, Inc.
- MDA
Awards
1
- 68015
European Commission
10.13039/501100000780
Region: Europe
gov (National government)
Labels
26
- European Union
- Comisión Europea
- Europäische Kommission
- EU-Kommissionen
- Euroopa Komisjoni
- Ευρωπαϊκής Επιτροπής
- Европейската комисия
- Evropské komise
- Commission européenne
- Choimisiúin Eorpaigh
- Europskoj komisiji
- Commissione europea
- La Commissione europea
- Eiropas Komisiju
- Europos Komisijos
- Európai Bizottságról
- Europese Commissie
- Komisja Europejska
- Comissão Europeia
- Comisia Europeană
- Európskej komisii
- Evropski komisiji
- Euroopan komission
- Europeiska kommissionen
- EC
- EU
Awards
2
- TRI-EX QLG2-CT-2001-01673
- POLYALA LSHM-CT-2005-018675